Nocturnal cerebral hypoxia in obstructive sleep apnoea: a randomised controlled trial
<p>Cerebral hypoxia may promote cerebral damage in patients with obstructive sleep apnoea (OSA). We investigated whether OSA patients experience nocturnal cerebral hypoxia that is prevented by continuous positive airway pressure (CPAP).</p> <p>OSA patients using CPAP underwent slee...
Auteurs principaux: | Schwarz, E, Furian, M, Schlatzer, C, Stradling, J, Kohler, M, Bloch, K |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
European Respiratory Society
2018
|
Documents similaires
-
ECG risk markers for atrial fibrillation and sudden cardiac death in minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised trial.
par: Schlatzer, C, et autres
Publié: (2016) -
Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: A systematic review and meta-analysis.
par: Schwarz, E, et autres
Publié: (2015) -
Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: A systematic review and meta-analysis
par: Schwarz, E, et autres
Publié: (2015) -
Pharmacological approaches to the treatment of obstructive sleep apnoea.
par: Kohler, M, et autres
Publié: (2009) -
The role of the nose in the pathogenesis of obstructive sleep apnoea and snoring.
par: Kohler, M, et autres
Publié: (2007)